Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer

They plan to study the genomic, transcriptomic, and proteomic responses of gastroesophageal tumors following treatment with Merck's Keytruda.

Related Keywords

Marijana Rucevic ,Andrew Nixon ,Duke University School Of Medicine ,Phasei Biomarker Laboratory ,Duke University ,Olink Proteomics ,Menlo Park ,California Based Personalis ,Duke University School ,Sweden Based Olink ,